Literature DB >> 7884651

Identifiability and indistinguishability of nonlinear pharmacokinetic models.

K R Godfrey1, M J Chapman, S Vajda.   

Abstract

Three nonlinear model structures of interest in pharmacokinetics are analyzed to determine whether the unknown, independent, model parameters can be deduced if perfect input-output data were available. This is the problem of identifiability. The method used is based on the local state isomorphism theorem. In certain circumstances, the modeler may be undecided between several model structures and it is then of interest to determine whether different model structures can be distinguished from perfect input-output data. This is the problem of model indistinguishability. The technique used, again based on the local state isomorphism theorem, parallels the similarity transformation approach for linear systems described previously in this journal. The analysis is performed on three two-compartment examples having one linear and one nonlinear (Michaelis-Menten) elimination pathway. In each model there is, on physiological and other grounds, some uncertainty over the precise location (central compartment or peripheral compartment) of one of the elimination pathways.

Mesh:

Year:  1994        PMID: 7884651     DOI: 10.1007/bf02353330

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  7 in total

1.  Do you need a pharmacokinetic model, and, if so, which one?

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1975-12

2.  Similarity transformation approach to identifiability analysis of nonlinear compartmental models.

Authors:  S Vajda; K R Godfrey; H Rabitz
Journal:  Math Biosci       Date:  1989-04       Impact factor: 2.144

3.  Pharmacokinetics of isoniazid and some metabolites in man.

Authors:  H G Boxenbaum; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

4.  Global identifiability of the parameters of nonlinear systems with specified inputs: a comparison of methods.

Authors:  M J Chappell; K R Godfrey; S Vajda
Journal:  Math Biosci       Date:  1990-11       Impact factor: 2.144

Review 5.  The problem of model indistinguishability in pharmacokinetics.

Authors:  K R Godfrey; M J Chapman
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

6.  The deterministic identifiability of nonlinear pharmacokinetic models.

Authors:  K R Godfrey; W R Fitch
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

7.  A nonlinear physiologic pharmacokinetic model: I. Steady-state.

Authors:  J G Wagner; G J Szpunar; J J Ferry
Journal:  J Pharmacokinet Biopharm       Date:  1985-02
  7 in total
  9 in total

1.  Nonlinearity detection: advantages of nonlinear mixed-effects modeling.

Authors:  E N Jonsson; J R Wade; M O Karlsson
Journal:  AAPS PharmSci       Date:  2000

Review 2.  Population pharmacokinetics of therapeutic monoclonal antibodies.

Authors:  Nathanael L Dirks; Bernd Meibohm
Journal:  Clin Pharmacokinet       Date:  2010-10       Impact factor: 6.447

3.  A general model-based design of experiments approach to achieve practical identifiability of pharmacokinetic and pharmacodynamic models.

Authors:  Federico Galvanin; Carlo C Ballan; Massimiliano Barolo; Fabrizio Bezzo
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-06-04       Impact factor: 2.745

4.  Steady-state volume of distribution of two-compartment models with simultaneous linear and saturated elimination.

Authors:  Xiaotian Wu; Fahima Nekka; Jun Li
Journal:  J Pharmacokinet Pharmacodyn       Date:  2016-07-12       Impact factor: 2.745

5.  Structural identifiability analysis of pharmacokinetic models using DAISY: semi-mechanistic gastric emptying models for 13C-octanoic acid.

Authors:  Kayode Ogungbenro; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2011-02-24       Impact factor: 2.745

6.  What do we mean by identifiability in mixed effects models?

Authors:  Marc Lavielle; Leon Aarons
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-12-10       Impact factor: 2.745

7.  An approach for identifiability of population pharmacokinetic-pharmacodynamic models.

Authors:  V Shivva; J Korell; I G Tucker; S B Duffull
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-06-19

8.  Inference of complex biological networks: distinguishability issues and optimization-based solutions.

Authors:  Gábor Szederkényi; Julio R Banga; Antonio A Alonso
Journal:  BMC Syst Biol       Date:  2011-10-28

9.  Priming nonlinear searches for pathway identification.

Authors:  Siren R Veflingstad; Jonas Almeida; Eberhard O Voit
Journal:  Theor Biol Med Model       Date:  2004-09-14       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.